Fleurieux-sur-l’Arbresle – France – December 17, 2025 – 8am - Safe (FR001400ZU25 – ALSAF) announces the signing of an exclusive distribution agreement with Vortrom Biologics, a subsidiary of Vortrom, ...

COPENHAGEN, Denmark, December 17, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that, following the recent appointment of Anne Louise Eberhard as new Chair of the Board of Directors, and in ...

In addition, members of the Rakovina team will participate in Fierce JPM Week as part of the week’s broader industry programming.

“If your cycle coincides with a busy social calendar, the combination of disrupted sleep, dehydration, inflammation and hormonal shifts can intensify cramps, worsen PMS and make period symptoms ...

CMR Surgical, a global medical technology company, today announces its second-generation surgical robotic platform, Versius Plus, has received 510 (k) clearance from the United States Food and Drug ...

Sanofi’s efdoralprin alfa earns orphan designation in the EU for alpha-1 antitrypsin deficiency related emphysema Additional orphan designation reinforces Sanofi’s commitment to developing treatments ...

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands First Genio implants successfully performed at OLVG West and Zuyderland hospitals ...

Paris, France – December 17, 2025. Sanofi announced today that its Q4 2025 Aide memoire is available on the "Investors" page of the company's website: Fourth quarter & full year 2025 results ...

Parties also enter into Management Services Agreement through closing which is expected in 1H’26 ...

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics, today announced that Parent Project Muscular Dystrophy (PPMD) will ...

DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4- ...

Medline Inc. (“Medline”) announced today the pricing of its upsized initial public offering of 216,034,482 shares of its Class A common stock, at a public offering price of $29.00 per share. Medline ...